Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
Insulin-induced hypoglycemia is a major treatment barrier in type-1 diabetes (T1D). Accordingly, it is important that we understand the mechanisms regulating the circulating levels of glucagon. Varying glucose over the range of concentrations that occur physiologically between the fed and fuel-depri...
मुख्य लेखकों: | Kim, A, Knudsen, J, Madara, J, Benrick, A, Hill, T, Abdul Kadir, L, Kellard, J, Mellander, L, Miranda, C, Lin, H, James, T, Suba, K, Spigelman, A, Wu, Y, MacDonald, P, Wenstedt Asterholm, I, Magnussen, T, Christensen, M, Visboll, T, Salem, V, Knop, F, Rorsman, P, Lowell, B, Briant, L |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
eLife Sciences Publications
2021
|
समान संसाधन
-
INTERLEUKIN-INDUCED VASOPRESSIN RELEASE IS INHIBITED BY L-ARGININE
द्वारा: Yasin, S, और अन्य
प्रकाशित: (1993) -
Interleukin-induced vasopressin release is inhibited by L-arginine.
द्वारा: Yasin, SA, और अन्य
प्रकाशित: (1993) -
Arginine vasopressin secretion in Kenyan children with severe malaria.
द्वारा: Sowunmi, A, और अन्य
प्रकाशित: (2000) -
Arginine vasopressin in the medial amygdala causes greater post-stress recruitment of hypothalamic vasopressin neurons
द्वारा: Tong, Wen Han, और अन्य
प्रकाशित: (2021) -
Role of arginine vasopressin in modulating plasticity in defensive behavior
द्वारा: Shantala Arundathi Hari Dass
प्रकाशित: (2014)